AAVLife: Another Gene Therapy Effort To Treat Friedreich's Ataxia
This article was originally published in Start Up
Executive Summary
With the launch of AAVLife, Versant Ventures adds to its gene therapy portfolio, and people with Friedreich's ataxia can look to another program that takes aim at the rare inherited disease.